Castle Biosciences Inc

CSTLNASDAQ · USD
34.87USD-1.06 (-2.95%)
6510

Castle Biosciences Inc (CSTL) Covered Calls

As of September 28, 2026, CSTL has 6 covered call opportunities in the coming three months. Return ranges from 14.5 to 42.8% until expiration. Annualized return ranges from 38.5 to 100.1%. The nearest expiration is November 20, 2026. Maximum potential profit is $1,537.

Read more

Running CSTL covered calls helps you generate consistent income from Castle Biosciences Inc's shares you already own, turning a long stock position into a yield-producing asset. A covered call on Castle Biosciences Inc involves holding the underlying stock and selling a call option against it, collecting premium in exchange for capping upside at the strike price. Use our scanner to find the best CSTL covered calls in real time and filter for the strikes, expiries, and premiums that fit your strategy.

A covered call is one of the most widely used options strategies because it pairs limited risk with a clear income profile: if CSTL stays below the strike at expiration, you keep the premium and the shares; if it rises above, you deliver the stock at the strike and still pocket the premium. Selling CSTL covered calls works best when implied volatility is elevated, since richer premiums improve the risk-reward. Key inputs to evaluate include strike selection relative to delta, days to expiration, annualized return, and the probability of assignment — all of which determine whether a given Castle Biosciences Inc covered call is worth writing.

Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company also offers DecisionDx-UM test, a proprietary GEP test that predicts the risk of metastasis for patients with uveal melanoma, a rare eye cancer; DecisionDx-SCC, a proprietary 40-gene expression profile test that uses an individual patient's tumor biology to predict individual risk of squamous cell carcinoma metastasis for patients with one or more risk factors; and DecisionDx DiffDx-Melanoma and myPath Melanoma, a proprietary GEP test to diagnose suspicious pigmented lesions.

It offers test services through physicians and their patients. The company was founded in 2007 and is headquartered in Friendswood, Texas.

Income-focused investors, long-term CSTL holders, and systematic premium sellers all face the same challenge: finding the covered call strike and expiry that balances yield against the risk of being called away. Our scanner ranks covered calls by annualized return, downside protection, and probability of profit, so selling CSTL covered calls becomes a measured decision instead of a guess. Stop eyeballing the chain — let the best Castle Biosciences Inc covered calls come to you, already filtered for the metrics that matter.

Stock Statistics

  • IndustryDiagnostics & Research
  • SectorHealthcare
  • IV percentile39.29% Neutral
  • Market cap (M$)1,098
  • 52 weeks high-18.86%
  • 52 weeks low102.77%
  • Analyst recommendationStrong Buy
    1.11
  • Target price$45.11
    26.18% above the current stock price
  • Dividend—
  • Payout ratio—
  • Earnings date2026-11-02
  • P/E—
  • Future P/E—
  • EPS (ttm)-0.65
  • EPS growth next 5 years21.93%

As of September 28, 2026

2026-11-205340.0011.331.152.90522.0014.53100.05-3.20+0.3811.75
2027-01-1510945.0025.240.802.40987.0027.4791.99-2.23+0.2841.60
2027-04-1620050.0039.161.304.001537.0042.7878.07-3.62+0.3202.70
2027-04-1620045.0025.242.105.001117.0031.0956.74-5.84+0.4002.90
2027-01-1510940.0011.331.554.40562.0015.6452.38-4.31+0.44142.85
2027-04-1620040.0011.333.507.00757.0021.0738.45-9.74+0.5203.50

As of September 28, 2026

Sell covered calls with the data behind you

Find the best CSTL covered call setups ranked by annualized return, filter by premium, delta, and days to expiration, and act on the opportunity in seconds.

Start your 14-day free trial